MI
IMCR icon

Motiv8 Investments’s Immunocore IMCR Stock Holding History

Motiv8 Investments’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2 Buy
+63
New +$2.22K ﹤0.01% 758

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Motiv8 Investments's IMCR Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Immunocore (IMCR) in Q4 2025: 63 shares worth $2. The stake represents ﹤0.01% of the portfolio and ranks #758 among its holdings.

149 funds tracked by Wall St. Rank hold IMCR as of Q4 2025.

  • Motiv8 Investments held 63 shares of Immunocore worth $2 as of Q4 2025.
  • Immunocore was a new Motiv8 Investments position in Q4 2025.
  • Immunocore made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #758 holding.
  • 149 funds tracked by Wall St. Rank held Immunocore as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.